Alignment Healthcare Lands 4.5 Stars on Three MA Contracts

Alignment Healthcare (NASDAQ: ALHC) said on Oct. 8, 2026 that six of its seven Medicare Advantage contracts eligible for rating earned 4 Stars or higher in the Centers for Medicare & Medicaid Services' 2027 Star Ratings, with three contracts reaching an overall 4.5-Star grade. The company's California H3815 HMO contract received 3.5 Stars for 2027, a result the company said does not reflect the contract's record on clinical outcomes and member experience. CMS published the 2027 ratings the same day.

The high-performing contracts span Arizona, California, Nevada, North Carolina and Texas, per the company. Alignment said it intends to pursue administrative remedies and to litigate the measures and methodologies it believes warrant review.

Context — Why the 2027 Star Ratings Matter Now

Star Ratings set the benchmark seniors use when comparing Medicare Advantage plans on Medicare.gov, and they feed directly into how CMS pays plans. That makes the annual release a revenue event as much as a quality report, and it explains why a single contract slipping below 4 Stars draws an outsized response from management.

The report gives no prior-year ratings for the same contracts, so the scale of any year-over-year change is not disclosed. What the company does provide is a directional claim: that the H3815 result is inconsistent with its performance and with other indicators of quality it tracks.

CMS released the 2027 ratings against a backdrop the company describes as ongoing legal and policy concerns over how MA plan performance is evaluated. Alignment said many industry stakeholders continue to question whether the framework consistently reflects care quality, member experience and clinical outcomes.

That dispute is the catalyst behind the company's public pushback. Rather than accept the score and move on, Alignment is contesting both the measures and the methodology, which turns a routine ratings disclosure into a potential legal process.

Dawn Maroney, president of Alignment Health and CEO of Alignment Health Plan, framed the issue as one of measurement accuracy rather than accountability. She said the company supports holding health plans accountable for results, because seniors deserve clear information when choosing coverage.

Data — What the Numbers Show

The headline count is six of seven rated contracts at 4 Stars or above, a hit rate of roughly 86%. Three of those contracts sit at 4.5 Stars. One contract, the California H3815 HMO, sits at 3.5 Stars.

Metric	2027 Star Ratings
Contracts eligible for rating	7
Contracts at 4 Stars or higher	6
Contracts at 4.5 Stars	3
California H3815 HMO	3.5 Stars
States covered by top contracts	AZ, CA, NV, NC, TX

The report does not disclose enrollment by contract, revenue tied to each contract, or the prior-year rating for H3815. It also does not give the individual measure-level scores that produced the 4.5-Star results. Enrollment figures referenced in the release are dated September 2026, and the ratings themselves are based on CMS data published Oct. 8, 2026.

Alignment said it maintained strong performance across numerous clinical and service measures evaluated under the program, including healthcare quality, care coordination, member experience and customer service. No measure-level detail was provided to quantify that claim.

The company's stated goal is to return H3815 to at least a 4-Star Rating. It did not give a timeline for that recovery or specify which rating year it expects to achieve it.

Analysis — What It Means for Markets and Sector Peers

Star Ratings are the clearest public quality signal in Medicare Advantage, and they influence which plans seniors select during enrollment periods. A 3.5-Star contract is still above the threshold that triggers CMS sanctions, but it sits below the 4-Star line that plans typically market on.

The exposure here is concentrated in ALHC. The company's own framing suggests the financial consequences hinge on whether the H3815 score holds through any appeals process, and on whether the remaining six contracts retain their grades. Alignment said its strategy remains unchanged despite the dispute.

The counter-argument is straightforward: ratings methodologies exist precisely so plans cannot grade themselves, and CMS has defended its framework through prior industry challenges. If Alignment's litigation fails, the 3.5-Star score stands, and the company has already told investors it believes the number is wrong — a position that becomes harder to maintain if regulators prevail.

The report does not quantify revenue or margin impact from the rating, so the earnings effect cannot be sized from the disclosure alone. What it does show is that management is willing to spend on legal process rather than absorb the score, which implies the company views the stakes as material.

Positioning is likely to hinge on the appeals timeline rather than the initial score. Investors holding ALHC for the quality narrative now carry event risk tied to litigation, while any fund screening on Star Ratings would see six of seven contracts clearing the 4-Star bar.

Outlook — What to Watch Next

The next hard data point is CMS's 2028 Star Ratings cycle, which the report does not date. Between now and then, the administrative remedies and any litigation Alignment pursues become the primary catalysts, since the company said it intends to challenge both measures and methodology.

Watch for disclosure on which specific measures the company is contesting. The report names none, so any detail on that front would be new information for the market.

Also watch enrollment trends in the affected markets. The release cites plan enrollment as of September 2026 but gives no contract-level figures, so any future disclosure of membership by contract would clarify how much revenue the H3815 rating actually touches.

Frequently Asked Questions

What does a 3.5-Star Medicare Advantage rating mean for members?

CMS rates Medicare Advantage plans on a five-star scale using member feedback, clinical quality indicators and customer service metrics, and publishes results on Medicare.gov. A 3.5-Star score is above the level that triggers CMS sanctions but below the 4-Star mark plans often highlight in marketing. Members can switch plans during enrollment periods, so ratings can influence retention. Alignment said the H3815 score does not reflect the contract's actual performance.

Why is Alignment Healthcare challenging its CMS Star Rating?

The company said the 2027 rating for its California H3815 HMO contract is inconsistent with its clinical outcomes and other quality indicators. Alignment stated it intends to pursue all available administrative remedies and to litigate the measures and methodologies it believes warrant review. CEO Dawn Maroney said the current framework has drifted from accurately reflecting quality, outcomes and member experience. The company did not specify which measures it plans to contest.

How many Alignment Healthcare contracts earned top Star Ratings for 2027?

Six of the company's seven Medicare Advantage contracts eligible for rating earned 4 Stars or higher, according to the company. Three of those reached an overall 4.5-Star Rating. The contracts span Arizona, California, Nevada, North Carolina and Texas. The seventh contract, California H3815 HMO, received 3.5 Stars. Alignment said it aims to return that contract to at least a 4-Star Rating.

Bottom Line

Alignment cleared 4 Stars on six of seven rated MA contracts but now carries litigation risk over the one that missed.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.